MedPath

Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center

Completed
Conditions
Addiction
Registration Number
NCT02245685
Lead Sponsor
Nantes University Hospital
Brief Summary

This study is part of the french priorities of the 2007-2011 addiction plan. Priority #2 of the plan underlines the need to improve practices and access to opioid substitution treatment. Priority 3 stresses the importance of articulation and coordination between specialized structures and community medicine to optimize the quality of care and to ensure continuity in the followup of these patients. This study focuses on the followup of patients under substitution therapy from the moment they enter a specialized care center for addicts to the period they are monitored by a general practitioner outside the specialized care center. The assessment described in this study should allow to harmonize and keep a continuity in patient monitoring.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
113
Inclusion Criteria
  • Patients entering a specialized medical care center for addicts
Exclusion Criteria
  • Patients refusing to sign the consent for participation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evolution of the severity score to heroin addiction (TMSP score)From the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)
Secondary Outcome Measures
NameTimeMethod
Evolution of the score of quality of life scaleFrom the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)
Evolution of the severity score to heroin addiction (TMSP score)From the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)

Trial Locations

Locations (1)

CSST "La Rose des Vents"

🇫🇷

Saint-Nazaire, France

© Copyright 2025. All Rights Reserved by MedPath